Vendor Versus Center of Excellence
What type of CDMO is the right fit for you? When it comes to outsourcing, there is often confusion about the type of partner that is most appropriate for a project. In our previous article, we discussed the difference between a CRO, CMO and CDMO. In this article,...
How the Netherlands became a key player for vaccine development
The Netherlands has a long history in the life sciences industry. Especially in the field of vaccine development and manufacturing, this small country has always played a significant role. Lately, the rich history proved a fertile ground for developing and...
Solving challenges in manufacturing viral vector based ATMPs
Written by expert: Kai, Technical Lead The obstacles of viral vector production Over the last decade, the scientific community has witnessed several breakthroughs in the field of gene therapy and immuno-oncology. These breakthroughs have propelled the interest in the...
How to work with a CDMO for viral vectors: 5 steps to success
5 Steps to successfully select a specialized CDMO for Viral Vectors and outsource your manufacturing project.
How to turn an innovative drug candidate into a commercial success – the product development plan explained
Behind every successful drug is a well-crafted product development plan. Read why and how to use this tool to formulate a winning strategy.
Guide To Viral Vector Production: From Bench to Bedside. Faster.
Explore this guide to viral vector process development and scale-up and accelerate your journey from bench to bedside.
Biotech startups – understanding the ecosystem for success
Today’s ecosystem for drug development has more symbiotic relationships between VC-backed pharma and biotech startups working to diffuse risk
How important is matrix effect in analyzing bioprocess samples?
How important is evaluation of the matrix effects when analyzing bioprocess samples? What are the best approaches to evaluate the effect? And in what situations is the matrix effect acceptable?
Adenovirus vectors: cutting edge delivery vehicles for gene therapy and vaccine development
Adenovirus vectors are vital to gene therapy, vaccine development, and cancer virotherapies. Learn more about these important delivery tools.
Taking your adenoviral vector product from R&D to the clinic
The road from R&D to final production of an adenoviral vector product is well trodden. Here is information to help you on your journey.
Univercells and consortium partners Batavia Biosciences and Natrix Separations Received $12 Million Grant by Bill & Melinda Gates Foundation to Radically Reduce Vaccine Costs for Developing Countries
Brussels, Belgium, December 15, 2016 – Univercells announced today that it has been awarded a $12 million grant by the Bill & Melinda Gates Foundation for the development of a breakthrough vaccine manufacturing platform with the objective of radically lowering...
Batavia enters commercial manufacturing
Read how Batavia Biosciences will extend its CDMO services portfolio to include commercial manufacturing services.
Batavia At LBSP ATMP TechTalks
Eize De Boer featured as prominent speaker at ATMP-themed TechTalks in the Leiden Bio Science Park.
LUMC & Batavia Biosciences Burst the Bubble
In this article, you can read about the journey UMC & Batavia undertook to cure a first patient with SCID in history.